| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2014 | 5-lipoxygenase inhibitors attenuate TNF-α-Induced inflammation in human synovial fibroblasts | Lin H.-C.; Lin T.-H.; Wu M.-Y.; Chiu Y.-C.; Tang C.-H.; Hour M.-J.; Liou H.-C.; Tu H.-J.; RONG-SEN YANG ; WEN-MEI FU | PLoS ONE | 41 | 36 | |
| 2017 | Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation | Sheng X.-J.; Tu H.-J.; Chien W.-L.; Kang K.-H.; Lu D.-H.; HORNG-HUEI LIOU ; MING-JEN LEE ; WEN-MEI FU | PLoS ONE | 11 | 13 | |
| 2019 | Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo | Hsieh Y.-L.; Tu H.-J.; Pan S.-L.; Liou J.-P.; CHIA-RON YANG | Biochimica et Biophysica Acta - Molecular Cell Research | 29 | 29 | |
| 2018 | The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells | Tu H.-J.; Lin Y.-J.; Chao M.-W.; Sung T.-Y.; Wu Y.-W.; Chen Y.-Y.; Lin M.-H.; Liou J.-P.; Pan S.-L.; CHIA-RON YANG | Clinical Epigenetics | 19 | 20 | |
| 2017 | ARHGEF10 knockout inhibits platelet aggregation and protects mice from thrombus formation | Lu D.-H.; Hsu C.-C.; Huang S.-W.; Tu H.-J.; TUR-FU HUANG ; Liou H.-C.; Liao H.-M.; Chen C.-H.; WEN-MEI FU ; SUSAN SHUR-FEN GAU | Journal of Thrombosis and Haemostasis | 9 | 10 | |
| 2017 | CXCL12/CXCR4 Signaling Contributes to the Pathogenesis of Opioid Tolerance: A Translational Study | CHIH-PENG LIN ; Kang K.-H.; Tu H.-J.; Wu M.-Y.; Lin T.-H.; Liou H.-C.; WEI-ZEN SUN ; WEN-MEI FU | Anesthesia and Analgesia | 13 | 13 | |
| 2013 | Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts | Tu H.-J.; Lin T.-H.; Chiu Y.-C.; Tang C.-H.; RONG-SEN YANG ; WEN-MEI FU | Journal of Cellular Physiology | 12 | 11 | |
| 2022 | Identification and analysis of a selective DYRK1A inhibitor | Lin T.E.; Chao M.-W.; HuangFu W.-C.; Tu H.-J.; Peng Z.-X.; Su C.-J.; Sung T.-Y.; Hsieh J.-H.; Lee C.-C.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Biomedicine and Pharmacotherapy | 3 | 2 | |
| 2021 | Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach | Chao M.-W.; Lin T.E.; HuangFu W.-C.; Chang C.-D.; Tu H.-J.; Chen L.-C.; Yen S.-C.; Sung T.-Y.; Huang W.-J.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 6 | 6 | |
| 2018 | Impairment of social behaviors in Arhgef10 knockout mice | Lu D.-H.; Liao H.-M.; Chen C.-H.; Tu H.-J.; Liou H.-C.; SUSAN SHUR-FEN GAU ; WEN-MEI FU | Molecular Autism | 18 | 19 | |
| 2017 | Inhibition of osteoporosis by the αvβ3 integrin antagonist of rhodostomin variants | Lin T.-H.; RONG-SEN YANG ; Tu H.-J.; Liou H.-C.; Lin Y.-M.; Chuang W.-J.; WEN-MEI FU | European Journal of Pharmacology | 16 | 15 | |
| 2015 | Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer | Hsu E.-C.; Kulp S.K.; Huang H.-L.; Tu H.-J.; Chao M.-W.; Tseng Y.-C.; Yang M.-C.; Salunke S.B.; Sullivan N.J.; Chen W.-C.; Zhang J.; Teng C.-M.; WEN-MEI FU ; Sun D.; Wicha M.S.; Shapiro C.L.; Chen C.-S. | Carcinogenesis | 19 | 15 | |
| 2021 | A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo | Wu Y.-W.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Hsu K.-C.; Liou J.-P.; CHIA-RON YANG ; Yen S.-C.; HuangFu W.-C.; Pan S.-L. | Oncogenesis | 11 | 8 | |
| 2022 | O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia | Yen S.-C.; Wu Y.-W.; Huang C.-C.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Lin T.E.; Sung T.-Y.; Tseng H.-J.; Chu J.-C.; Huang W.-J.; CHIA-RON YANG ; HuangFu W.-C.; Pan S.-L.; Hsu K.-C. | Phytomedicine | 4 | 5 |
